Regatta Research & Money Management’s AbbVie ABBV Stock Holding History

Regatta Research & Money Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$82.1K	Buy	+327	New	+$70.4K	0.08%	200

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Regatta Research & Money Management's ABBV Position: Q2 2026 in Review

Regatta Research & Money Management opened a new position in AbbVie (ABBV) in Q2 2026: 327 shares worth $82.1K. The stake represents 0.08% of the portfolio and ranks #200 among its holdings.

3,548 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Regatta Research & Money Management held 327 shares of AbbVie worth $82.1K as of Q2 2026.
AbbVie was a new Regatta Research & Money Management position in Q2 2026.
AbbVie made up 0.08% of Regatta Research & Money Management's portfolio in Q2 2026, its #200 holding.
3,548 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Regatta Research & Money Management's 13F filing for Q2 2026, filed 12 Aug 2026.